Despite much advancement in diagnosis and treatment for this disease, the prognosis of BRAF-mutant CRC patients is still very poor because of obstinate recurrence and distant metastasis (Eefsen et al., 2015; Malik et al., 2015). The gene discussed is BRAF; the disease is colorectal carcinoma.